Genentech's Acquisition Of Tanox Does Not Represent A Strategic Shift, CEO Says

Genentech will continue to set a "high bar" for acquisitions after buying Xolair partner Tanox for $919 mil., firm says.

More from Archive

More from Pink Sheet